Aphranel® News & Media: CaHA Regenerative Aesthetics Updates

MOYOM advances APHRANEL® in Europe through EU MDR certification and a long-term scientific collaboration with Dr. Patrick Trévidic’s Expert2Expert team.

Following nearly 150,000 syringes distributed worldwide, aphranel® officially achieved EU MDR certification under Regulation (EU) 2017/745 during its first anniversary summit in Shanghai.

aphranel® officially obtained European Union MDR certification on May 18, 2026, becoming the only CaHA product in the Asia-Pacific region currently certified under the EU MDR framework.

aphranel® hosted its “Twin Peaks Lecture” at the Roma exhibition in Shanghai, bringing together experts from regenerative aesthetics, fashion, craftsmanship, and cultural heritage to explore the relationship between time, beauty, and human expression.

At IMCAS Paris 2026, aphranel® officially introduced its global brand philosophy, The Poetics of Time — a long-term regenerative aesthetics approach centered on structure, collagen regeneration, and natural beauty evolving through time.

On May 8, 2025, Shanghai Moyom Biotechnology officially unveiled aphranel® MagiCCrystal (Injectable Calcium Hydroxyapatite Microsphere Facial Filler) at its global launch event held at the Shanghai World Reception Hall.